Icon (ICLR) Gets a Buy from Truist Financial
In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Icon (ICLR – Research Report). The company’s ...
ICON Public targets 1.2x book-to-bill ratio in 2025 amid strategic partnership growth
Q4 2024 Management View CEO Steve Cutler introduced Barry Balfe as the newly appointed COO, highlighting his 20-year tenure at ICON and focus on strengthening strategic partnerships across the ...
Icon backs FY25 adjusted EPS view $13.00-$15.00, consensus $14.20
Backs FY25 revenue view $8.05B-$8.65B, consensus $8.4B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Icon Launches New $750M Share Buyback
Icon plc has launched a new buyback program to repurchase up to $750 million of its shares. The total value of the authorized share repurchase is now up to $1 billion, the healthcare intelligence and ...
Researcher ICON Sued by Investor Over Revenue Miss Stock Dive
Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...
Yahoo Finance3d
ICON Public Limited Company (ICLR)
For the year the […] DUBLIN, January 30, 2025--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its ...